Dr. Fumio Tsuji
My Social Links

Dr. Fumio Tsuji

Research Scientist
Santen Pharmaceutical Co., Ltd., Japan


Highest Degree
Ph.D. in Pharmaceutical Sciences from Gifu University, Gifu, Japan

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Immunopharmacology
62%
Pharmaceutical Sciences
90%
Pharmacogenetics
75%
Leukotriene
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
10
Abstracts
0

Selected Publications

  1. Tsukahara-Ohsumi, Y., F. Tsuji, M. Niwa, M. Nakamura and K. Mizutani et al., 2010. SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects. Eur. J. Pharmacol., 647: 62-67.
    CrossRef  |  PubMed  |  Direct Link  |  
  2. Tsuji, F., M. Murai, K. Oki, I. Seki and K. Ueda et al., 2010. Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents. Eur. J. Pharmacol., 627: 332-339.
    CrossRef  |  PubMed  |  Direct Link  |  
  3. Tsuji, F., H. Aono, T. Tsuboi, T. Murakami, H. Enomoto, K. Mizutani and N. Inagaki, 2010. Role of leukotriene B4 in 5-lipoxygenase metabolite- and allergy-induced itch-associated responses in mice. Biol. Pharm. Bull., 33: 1050-1053.
    CrossRef  |  PubMed  |  Direct Link  |  
  4. Setoguchi, C., F. Tsuji, O. Katsuta, M. Okamoto and H. Aono, 2010. Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model. Mod. Rheumatol., 20: 381-388.
    CrossRef  |  PubMed  |  Direct Link  |  
  5. Tsuji, F., M. Yoshimi, O. Katsuta, M. Takai, K. Ishihara and H. Aono, 2009. Point mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice. BMC Musculoskelet. Disord., 10: 23-23.
    CrossRef  |  PubMed  |  Direct Link  |